About Us

Triventures is a venture capital fund focused on data driven
healthcare solutions and disruptive medical devices.
We invest in early to late stage opportunities in Israel, US and Europe.

700 +
companies reviewed annually
$ 180 M
100 +
cumulative years
of experience

Who We Are

Founded in 2010, Triventures is a global, multi-stage venture capital firm, seed and beyond, that invests in startups led by exceptional entrepreneurs. We identify cross-industry breakthroughs that converge the best in class in health and non-health technologies such as insuretech and fintech for healthcare, e-commerce and cyber for healthcare, community driven genomics, health data marketplaces and more.

Our global footprint includes offices in Israel and the Silicon Valley.

What We Believe

We believe healthcare is undergoing a revolution and that the industry’s future is now. The data driven health market is expected to grow 6X in the coming years, exceeding $500B by 2025.


These figures are supported by a wave of global success stories including significant equity financings, M&As and IPOs, demonstrating that the market is maturing and transitioning from pilot to scale.


Cross-industry influences are becoming more prevalent with participants from retail, tech, insurance, entertainment and telecommunications exploring creative opportunities to pair their tech and domain expertise with healthcare.


Data driven health is our future and Triventures’ accumulated domain experience, unique partnerships and access to data helps outstanding entrepreneurs build companies that transform the industry.

How We Invest

Our funds are focused on seed, A and B rounds enabling us to support a company’s continuum of investments. Our seed vehicle, Triventures ARC, focuses on the earliest stages of a venture while our post-seed funds allow us to invest in more mature opportunities.


We invest in visionary people and solutions that leverage opportunities in converging domains. There are many factors that contribute to building successful ventures but for us, the key parameters are the management team, the market potential, impact on the industry and strategic landscape.


When we evaluate a new opportunity, we invest time getting to know the team, problem and solution. Our diligence is comprehensive – we analyze hard facts such as market size, commercial integration and business models. We also consider softer parameters such as do the entrepreneurs complement each other? Is there the right balance of IQ/EQ? Is this an agile, adaptive team?


When we invest in a company, we become partners for the long term and these early interactions are crucial for determining whether there is a good fit between us.

What We Offer

We provide unprecedented access to data, a strategic network of partners and accumulated domain expertise. Through our exclusive partnership with one of the top 10 hospitals in the world, Sheba Medical Center, our portfolio benefits from over two decades of longitudinal digitized data. Our strategic investors are global leaders in healthcare, insurance, telecommunications and consumer electronics and understand what it takes to commercially integrate solutions into the market – we leverage this knowledge across our portfolio. We are hands-on investors coming from entrepreneurial backgrounds and like to roll-up our sleeves to help our portfolio companies in any way that they need.

Introducing Triventures ARC

Triventures ARC is the seed stage fund of Triventures in an exclusive collaboration with Sheba Medical Center, one of the world’s top 10 hospitals. This is the first partnership of its kind between an Israeli healthcare system and a venture capital fund that will leverage over two decades of digitized patient data amassed by Sheba.


The fund focuses on data driven solutions in areas such as:

• Personalized Healthcare
• Preventive Healthcare
• Healthcare Accessibility
• Smart Medical Devices
• Administrative & Clinical Workflow
• Cybersecurity for Healthcare
• Fintech & Insurtech for Healthcare

What's your venture?
Drop us a line!